Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(−/−) mice

BACKGROUND AND AIMS: Obesity, hepatosteatosis, and hypertriglyceridemia are components of the metabolic syndrome and independent risk factors for cardiovascular disease. The lipid droplet-associated protein CIDEC (cell death-inducing DFFA-like effector C), known in mice as FSP27 (fat-specific protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajamoorthi, Ananthi, Lee, Richard G., Baldán, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113075/
https://www.ncbi.nlm.nih.gov/pubmed/29859472
http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113075/
https://www.ncbi.nlm.nih.gov/pubmed/29859472
http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.045

Ejemplares similares